Plasma Services Group provides sera and other samples for materials of control reagents and calibrators for a variety of diseases.

With the registration, the analyzer can be used for clinical testing in South Korea, expanding Quanterix's reach in that country's in vitro diagnostic and clinical laboratory markets.

Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to ...

NEW YORK – Researchers at Yale and Rutgers universities have developed a fast method to detect rare disease-causing point mutations directly from blood. Using a novel amplification technology coupled ...

Adding the firm's multi-cancer early detection test to standard-of-care screening demonstrated substantially greater additional cancer detection than in Pathfinder.

NEW YORK – Qiagen announced on Wednesday that it has launched a third-party partnering program for its clinical digital PCR platform and signed an agreement with the program's inaugural partner, South ...

Castle's first disease target is atopic dermatitis, with the goal to develop a test that can predict future flare-ups of the disease.

NEW YORK – In a letter to customers on Wednesday, Bio-Rad Laboratories announced that it has decided against implementing a tariff surcharge that the company on May 21 said it was considering for at ...

Owner Zishan Alvi submitted claims for COVID-19 tests that were either never performed or were performed incorrectly, releasing potentially false negative test results to patients.